期刊文献+

HIF-1α、NF-κB在大鼠不同程度非酒精性脂肪肝中的表达 被引量:3

Expression of HIF-1α and NF-κB in non-alcoholic fat liver disease in rats
下载PDF
导出
摘要 目的:探讨缺氧诱导因子1α(hypoxia-inducible factor 1α,HIF-1α)、核因子-κB(nuclear factor k a p p a B,N F-κB)在非酒精性脂肪肝炎(n o nalcoholic fat liver diseases,NAFLD)进展中的作用及其机制.方法:选50只♂SD大鼠随机分为正常组、模型组(高脂饮食4、8、12及16 wk组),每组10只.通过高脂饲料建立大鼠脂肪肝模型,取外周血及肝脏组织,进行血脂、肝功能、空腹血糖及病理组织学检查.Real-time-PCR法检测肝组织中HIF-1α、NF-κB的m RNA水平,多组计量资料比较采用成组设计的方差分析、Kruskal-Wallis H检验,两两比较采用LSD法,P<0.05为差异有统计学意义.结果:在高脂饮食第12周、16周,模型组的丙氨酸氨基转移酶(alanine amiotransferase,ALT)、三酰甘油(triglyceride,TG)和胆固醇(c h o l e s t e r o l,C H O L)水平与正常组相比均显著升高(P<0.05),而高密度脂蛋白胆固醇(high-density lipoprotein cholesterol,HDL-C)的表达则显著下降(P<0.05).HIF-1α和NF-κB表达随着高脂饮食时间的延长,表达逐渐升高(P<0.05),与脂肪肝的严重程度呈正比,且HIF-1α的表达与NF-κB具有相关性(r=0.67,P<0.05).结论:HIF-1α/NF-κB信号在大鼠NAFLD的进展中起着一定的促进作用. AIM: To investigate the role of hypoxia-inducible factor -1α (HIF-1α) and nuclear transcription factor κB (NF-κB) in the development of non-alcoholic fat liver disease (NAFLD) using a rat model. METHODS: Fifty SD rats were randomly divided into five groups (a normal group, a 4 wk model group, an 8 wk group, a 12 wk and a 16 wk group). NAFLD was induced in rats by administration of a high fat diet. Serum biochemical parameters were tested, and fiver histological changes were observed. HIF-1α and NF-κB mRNA expression was detected by real-time PCR. RESULTS: Compared with the normal group, significant elevations of serum alanine amiotransferase (ALT), triglyceride (TG), and cholesterol (CHOL) and reduction of high-density lipoprotein cholesterol (HDL-C) were observed in rats given a high fat diet for 12 wk or 16 wk (P 〈 0.05). In the model groups, liver steatosis, inflammation grade and degree of fibrosis were significantly aggravated. HIF-1α and NF- κB expression increased gradually with the severity of NAFLD (P 〈 0.05). CONCLUSION: HIF-1α/NF-κB signaling may be related to the development of NAFLD.
出处 《世界华人消化杂志》 CAS 北大核心 2014年第35期5480-5485,共6页 World Chinese Journal of Digestology
基金 江苏省分子影像重点实验室开放基金资助项目 No.PYZX2011012 无锡市科技局立项课题基金资助项目 No.CSZ00N1249~~
关键词 非酒精性脂肪肝 缺氧诱导因子-1Α 核转录因子-ΚB 表达 Non-alcoholic fat liver disease Hypoxia-inducible factor-1α Nuclear transcription factor κB Expression
  • 相关文献

参考文献15

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南.中华肝脏病杂志,2006,14:161-163.
  • 2Yan BC, Hart JA. Recent developments in liver pa- thology. Arch Pathol Lab ivied 2009; 133:1078-1086 [PMID: 19642734 DOI: 10.1043/1543-2165-133.7. 1078].
  • 3Moon JO, Welch TP, Gonzalez FJ, Copple BL. Re- duced liver fibrosis in hypoxia-inducible factor- 1alpha-deficient mice. Am J Physiol Gastrointest Liver Physiol 2009; 296:G582-G592 [PMID: 19136383 DOI: 10.1152/ajpgi.90368.2008].
  • 4Farrell GC, Teoh NC, McCuskey RS. Hepatic micro- circulation in fatty liver disease. Anat Rec (Hoboken) 2008; 291:684-692 [PMID: 18484615 DOI: 10.1002/ ar.20715].
  • 5Hasegawa T, Ito Y, Wijeweera J, Liu J, Malle E, Farhood A, McCuskey RS, Jaeschke H. Reduced inflammatory response and increased microcir- culatory disturbances during hepatic ischemia- reperfusion injury in steatotic livers of ob/ob mice. Am J Physiol Gastrointest Liver Physiol 2007; 292:G1385-G1395 [PMID: 17307725 DOI: 10.1152/ ajpgi.00246.2006].
  • 6Siegmund SV, Brenner DA. Molecular patho- genesis of alcohol-induced hepatic fibrosis. Alcohol Clin Exp Res 2005; 29: 102S-109S [PMID: 16344593 DOI: 10.1097/01.alc.0000189275.97419. 58].
  • 7沈卫东,刘鹏飞,邹大中,陈宏林.脂肪肝超声定量诊断与肝脏血流动力学、临床指标的关系[J].山东医药,2008,48(37):41-42. 被引量:8
  • 8杨月霞,黄文新.HIF-1在缺血缺氧性疾病中的研究进展[J].山东医药,2010,50(20):111-112. 被引量:15
  • 9王健(综述),郝继辉(审校).HIF-1α在肿瘤乏氧微环境中的作用及其靶向治疗的研究进展*[J].中国肿瘤临床,2013,40(17):1072-1075. 被引量:18
  • 10Carmeliet P, Dor Y, Herbert JM, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Cotlen D, Keshert E. Role of HIF-lalpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394:485-490 [PMID: 9697772 DOI: 10.1038/ 28867].

二级参考文献33

  • 1李启芳,戴爱国.Hypoxia-inducible factor-1 alpha regulates the role of vascular endothelial growth factor on pulmonary arteries of rats with hypoxia-induced pulmonary hypertension[J].Chinese Medical Journal,2004(7):1023-1028. 被引量:39
  • 2Tang CM, Yu J. Hypoxia-inducible factor-1 as a therapeutic tar- get in cancer[J].J Gastroenterol Hepatol, 2013, 28(3):401-405.
  • 3Dai CX, Gao Q, Qiu SJ, et al. Hypoxia--inducible factor-1 alpha, in association with inflammation, angiogenesis and MYC, is a criti- cal prognostic factor in patients with HCC after surgery[J]. BMC Cancer, 2009, 9:418.
  • 4Meijer TW, Kaanders JH, Span PN, et al. Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy effi- cacy[J]. Clin Cancer Res, 2012, 18(20):5585-5594.
  • 5Yu B, Miao ZH, Jiang Y, et al. c-Jun protects hypoxia-inducible factor--lalpha from degradation via its oxygen-dependent degrada- tion domain in a nontranscriptional manner[J]. Cancer Res, 2009, 69(19):7704-7712.
  • 6Han ZB, Ren H, Zhao H, et al. Hypoxia-inducible factor (HIF)-1 alpha directly enhances the transcriptional activity of stem cell fac- tor (SCF) in response to hypoxia and epidermal growth factor (EGF)[J].Carcinogenesis, 2008, 29(10):1853-1861.
  • 7Cha ST, Chen PS, Johansson G, et al. MicroRNA-519c suppresses hypoxia-inducible factor-lalpha expression and minor angiogene- sis[J]. Cancer Res, 2010, 70(7):2675-2685.
  • 8Baba Y, Nosho K, Shima K, et al. HIF1A overexpression is associat- ed with poor prognosis in a cohort of 731 colorectal cancers[J]. Am J Pathol, 2010, 176(5):2292-2301.
  • 9Ioannou M, Papamichali R, Kouvaras E, et al, Hypoxia inducible factor-1 alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma[J]. Lung, 2009, 187(5):321-329.
  • 10Gravdal K, Halvorsen oJ, Haukaas SA, et al. Proliferation of imma ture tumor vessels is a novel marker of clinical progression in pros- tare cancer[J]. Cancer Res, 2009, 69(11):4708-4715.

共引文献42

同被引文献24

  • 1中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.非酒精性脂肪性肝病诊疗指南[J].中华糖尿病杂志,2010,2(1). 被引量:523
  • 2Fattly Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].实用肝脏病杂志,2007,10(1):1-3. 被引量:144
  • 3Lemoine M. Non-alcoholic fatty liver disease : overview of the nat- ural history[J]. Gastroent6rologie Clinique et Biologique, 2009, 33(5) : 398 -404.
  • 4Zou Y, Li J, Lu C, et al. High-fat emulsion-induced rat model of nonalcoholic steatohepatitis [ J ]. Life Sci, 2006, 79 ( 11 ) : 1100 - 1107.
  • 5Ascencio C, Tortes N, Isoard-Acosta F, et al. Soy protein affects serum insulin and hepatic SREBP-1 mRNA and reduces fatty liver in rats[J]. J Nutr, 2004, 134(3) : 522 -529.
  • 6Villeneuve JP, Pichette V. Cytochrome P450 and liver diseases [J]. Curt Drug Metab, 2004, 5(3) : 273 -282.
  • 7Chtioui H, Seme|a D, Ledermann M, et al. Expression and activ- ity of the cytochrome 17450 2El in patients with nonalcoholic steatosis and steatohepatitis [ J ]. Liver Int, 2007, 27 (6) : 764 - 771.
  • 8Peng X, Zhang P, Wang X, et al. Activation of IKK and MAPK by thymosin alphal hepatology[ J]. Ann N Y Acard Sci ,2007,1112 : 339 - 350.
  • 9Fisher CD, Lickteig AJ, Augustine LM, et al. Hepatic cyto- chrome P450 enzyme alterations in humans with progressive stages of nonalcoholic fatty liver disease [ J ]. Drug Metab Dispos, 2009, 37(10) : 2087 -2094.
  • 10秦艳,张晾,潘杰.高脂饮食对非酒精性脂肪肝影响机制研究进展[J].实用肝脏病杂志,2010,13(1):72-74. 被引量:29

引证文献3

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部